SCHEMBL23013296

SCHEMBL23013296

O=C(O)c1c(-c2cccc(F)c2F)nn2cccnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 2/20 0.43
CCNE1 P24864 2/20 0.43
CDK2 P24941 2/20 0.43
PIK3CD O00329 3/20 0.40
PIK3CG P48736 3/20 0.40
PIK3R1 P27986 1/20 0.40
PIK3R2 O00459 2/20 0.38
PTGS2 P35354 1/20 0.37
DHODH Q02127 2/20 0.36
APOBEC3A P31941 2/20 0.36
APOBEC3G Q9HC16 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36
STING1 Q86WV6 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
GRK6 P43250 1/20 0.34
KCNQ3 O43525 2/20 0.34
KCNQ2 O43526 2/20 0.34
TGFBR1 P36897 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29703840 1.00 CCNE2 (0.43) CCNE2CCNE1CDK2PIK3CDPIK3CG
SCHEMBL23013809 0.90 DHODH (0.42) CCNE2CCNE1CDK2PIK3CDPIK3CG
SCHEMBL29703839 0.90 DHODH (0.42) CCNE2CCNE1CDK2PIK3CDPIK3CG
SCHEMBL27230025 0.87 IRAK4 (0.35) PIK3CDPIK3CGPIK3R1PIK3R2PTGS2
SCHEMBL23023568 0.86 PTGS2 (0.41) PIK3CDPIK3CGPIK3R1PIK3R2PTGS2
SCHEMBL29939624 0.85 DHODH (0.43) PIK3CDPIK3CGPIK3R2PTGS2DHODH
SCHEMBL29939637 0.83 TGFBR1 (0.41) CCNE2CCNE1CDK2ALDH1A1TGFBR1
SCHEMBL29939530 0.81 PTGS2 (0.41) PIK3CDPIK3CGPIK3R1PIK3R2PTGS2
SCHEMBL29939646 0.81 KMO (0.42) PIK3CDPIK3CGPIK3R1PIK3R2PTGS2
SCHEMBL29903325 0.81 RORC (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 US disclosed
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-10-13 US disclosed
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-09-29 US disclosed
EP-4017856-A1 PHARMACEUTICAL COMPOUNDS Reviral Limited (GB) 2022-06-29 EP disclosed
WO-2021032992-A1 PHARMACEUTICAL COMPOUNDS ReViral Limited (GB) 2021-02-25 WO disclosed
WO-2021032992-A1 PHARMACEUTICAL COMPOUNDS ReViral Limited (GB) 2021-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227507-B2 Pharmaceutical compounds CHRNA6, GABRA6, CHRNA7 CCNE2 1312/4885CCNE1 1394/4885CDK2 2023/4885
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 CCNE2 931/4885CCNE1 998/4885CDK2 1546/4885
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS CHRNA6, GABRA6, CHRNA7 CCNE2 1312/4885CCNE1 1394/4885CDK2 2023/4885
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS GABRA6, CNR1, CHRNA6 CCNE2 1006/4885CCNE1 977/4885CDK2 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.